{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:05:50Z","timestamp":1775207150139,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02146-y","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:10:16Z","timestamp":1775135416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics identification of a programmed cell death-related signature and potential target P4HB for bladder cancer based on a 101-combination machine learning and experimental validation"],"prefix":"10.1007","volume":"26","author":[{"given":"Yang","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"1","key":"2146_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2146_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carrion A, Cathomas R, Comperat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, Mertens LS, Meijer RP, Milowsky MI, Neuzillet Y, Panebianco V, Redlef J, Rink M, Rouanne M, Thalmann GN, Saebjornsen S, Veskimae E, van der Heijden AG. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol. 2024;85(1):17\u201331.","journal-title":"Eur Urol"},{"issue":"3","key":"2146_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","volume":"33","author":"T Powles","year":"2022","unstructured":"Powles T, Bellmunt J, Comperat E, De Santis M, Huddart R, Loriot Y, Necchi A, Valderrama BP, Ravaud A, Shariat SF, Szabados B, van der Heijden MS, Gillessen S. E.G.C.E.a. clinicalguidelines@esmo.org, Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(3):244\u201358.","journal-title":"Ann Oncol"},{"issue":"2","key":"2146_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/BLC-220109","volume":"9","author":"YA Wang","year":"2023","unstructured":"Wang YA, Ranti D, Bieber C, Galsky M, Bhardwaj N, Sfakianos JP, Horowitz A. NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors. Bladder Cancer. 2023;9(2):125\u201339.","journal-title":"Bladder Cancer"},{"issue":"8","key":"2146_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41585-022-00611-3","volume":"19","author":"A Martin","year":"2022","unstructured":"Martin A, Woolbright BL, Umar S, Ingersoll MA, Taylor JA 3. Bladder cancer, inflammageing and microbiomes. Nat Rev Urol. 2022;19(8):495\u2013509.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2146_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, Chen Y, Han B. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2146_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40291-018-0329-9","volume":"22","author":"AP Mishra","year":"2018","unstructured":"Mishra AP, Salehi B, Sharifi-Rad M, Pezzani R, Kobarfard F, Sharifi-Rad J, Nigam M. Programmed Cell Death, from a Cancer Perspective: An Overview. Mol Diagn Ther. 2018;22(3):281\u201395.","journal-title":"Mol Diagn Ther"},{"key":"2146_CR8","doi-asserted-by":"publisher","first-page":"104920","DOI":"10.1016\/j.ebiom.2023.104920","volume":"99","author":"K Cao","year":"2024","unstructured":"Cao K, Zhu J, Lu M, Zhang J, Yang Y, Ling X, Zhang L, Qi C, Wei S, Zhang Y, Ma J. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma. EBioMedicine. 2024;99:104920.","journal-title":"EBioMedicine"},{"key":"2146_CR9","doi-asserted-by":"crossref","unstructured":"Xiao F, Li HL, Yang B, Che H, Xu F, Li G, Zhou CH, Wang S. Disulfidptosis: A new type of cell death, Apoptosis (2024).","DOI":"10.1007\/s10495-024-01989-8"},{"key":"2146_CR10","doi-asserted-by":"publisher","first-page":"216867","DOI":"10.1016\/j.canlet.2024.216867","volume":"591","author":"K Liu","year":"2024","unstructured":"Liu K, Chen H, Li Y, Wang B, Li Q, Zhang L, Liu X, Wang C, Ertas YN, Shi H. Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics. Cancer Lett. 2024;591:216867.","journal-title":"Cancer Lett"},{"issue":"1","key":"2146_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12951-022-01575-7","volume":"20","author":"YC Chin","year":"2022","unstructured":"Chin YC, Yang LX, Hsu FT, Hsu CW, Chang TW, Chen HY, Chen LY, Chia ZC, Hung CH, Su WC, Chiu YC, Huang CC, Liao MY. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation. J Nanobiotechnol. 2022;20(1):373.","journal-title":"J Nanobiotechnol"},{"key":"2146_CR12","doi-asserted-by":"crossref","unstructured":"Xu L, Su B, Mo L, Zhao C, Zhao Z, Li H, Hu Z, Li J. Norcantharidin Induces Immunogenic Cell Death of Bladder Cancer Cells through Promoting Autophagy in Acidic Culture. Int J Mol Sci 2022;23(7): 3944.","DOI":"10.3390\/ijms23073944"},{"issue":"6","key":"2146_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, Gupta S, Smith AB, Williams SB, Lotan Y. Epidemiology, Screening, and Prevention of Bladder Cancer. Eur Urol Oncol. 2022;5(6):628\u201339.","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"2146_CR14","first-page":"130","volume":"30","author":"M Cao","year":"2024","unstructured":"Cao M, Cao Y, Xue S, Zhang Q, Zhang H, Xue W. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer. Altern Ther Health Med. 2024;30(4):130\u20138.","journal-title":"Altern Ther Health Med"},{"issue":"3","key":"2146_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/0008-5472.CAN-23-2278","volume":"84","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Chen J, Zheng H, Luo Y, An M, Lin Y, Pang M, Li Y, Kong Y, He W, Lin T, Chen C. SUMOylation-Driven mRNA Circularization Enhances Translation and Promotes Lymphatic Metastasis of Bladder Cancer. Cancer Res. 2024;84(3):434\u201348.","journal-title":"Cancer Res"},{"issue":"1","key":"2146_CR16","doi-asserted-by":"publisher","first-page":"e31501","DOI":"10.1002\/jcp.31501","volume":"240","author":"L Guo","year":"2025","unstructured":"Guo L, Zhao Y, Bai X, Wang X, Tuoheti K, Cao Y, Zuo Y, Zhang X, Liu T. RRM2 Is a Putative Biomarker and Promotes Bladder Cancer Progression via PI3K\/AKT\/mTOR Pathway. J Cell Physiol. 2025;240(1):e31501.","journal-title":"J Cell Physiol"},{"key":"2146_CR17","doi-asserted-by":"crossref","unstructured":"Barbour JA, Ou T, Yang H, Fang H, Yue NC, Zhu X, Wong-Brown MW, Wong YT, Bowden NA, Wu S, Wong JWH. ERCC2 mutations alter the genomic distribution pattern of somatic mutations and are independently prognostic in bladder cancer. Cell Genom 2024;4(8):100627.","DOI":"10.1016\/j.xgen.2024.100627"},{"issue":"1","key":"2146_CR18","doi-asserted-by":"publisher","first-page":"102927","DOI":"10.1016\/j.arcmed.2023.102927","volume":"55","author":"T Wang","year":"2024","unstructured":"Wang T, Ding G, Wang X, Cui Y, Ma X, Ma J, Wu J. Expression of EPB41L2 in Cancer-Associated Fibroblasts: Prognostic Implications for Bladder Cancer and Response to Immunotherapy. Arch Med Res. 2024;55(1):102927.","journal-title":"Arch Med Res"},{"issue":"13","key":"2146_CR19","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.2174\/0113862073273633231113060429","volume":"27","author":"D Jiang","year":"2024","unstructured":"Jiang D, Zhang H, Yin B, He M, Lu X, He C. The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K\/AKT Signaling Pathway. Comb Chem High Throughput Screen. 2024;27(13):1984\u201398.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"1","key":"2146_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12885-024-12489-y","volume":"24","author":"X Zhang","year":"2024","unstructured":"Zhang X, Hong B, Li H, Zhao J, Li M, Wei D, Wang Y, Zhang N. Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer. BMC Cancer. 2024;24(1):746.","journal-title":"BMC Cancer"},{"key":"2146_CR21","doi-asserted-by":"publisher","first-page":"1291720","DOI":"10.3389\/fonc.2023.1291720","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, Lin J, Wen Y, Chen Y, Chen CB. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma. Front Oncol. 2023;13:1291720.","journal-title":"Front Oncol"},{"issue":"1","key":"2146_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12894-023-01382-8","volume":"23","author":"S Zhu","year":"2023","unstructured":"Zhu S, Zhao Q, Fan Y, Tang C. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings. BMC Urol. 2023;23(1):199.","journal-title":"BMC Urol"},{"issue":"1","key":"2146_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10142-022-00957-2","volume":"23","author":"C Shen","year":"2023","unstructured":"Shen C, Yan Y, Yang S, Wang Z, Wu Z, Li Z, Zhang Z, Lin Y, Li P, Hu H. Construction and validation of a bladder cancer risk model based on autophagy-related genes. Funct Integr Genomics. 2023;23(1):46.","journal-title":"Funct Integr Genomics"},{"issue":"3","key":"2146_CR24","doi-asserted-by":"publisher","first-page":"e25573","DOI":"10.1016\/j.heliyon.2024.e25573","volume":"10","author":"G Pan","year":"2024","unstructured":"Pan G, Xie H, Xia Y. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer. Heliyon. 2024;10(3):e25573.","journal-title":"Heliyon"},{"issue":"3","key":"2146_CR25","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/tox.24066","volume":"39","author":"Z Li","year":"2024","unstructured":"Li Z, Li Y, Liu L, Zhang C, Li X. Multiple programmed cell death patterns and immune landscapes in bladder cancer: Evidence based on machine learning and multi-cohorts. Environ Toxicol. 2024;39(3):1780\u2013801.","journal-title":"Environ Toxicol"},{"key":"2146_CR26","doi-asserted-by":"publisher","first-page":"1572034","DOI":"10.3389\/fimmu.2025.1572034","volume":"16","author":"H Yan","year":"2025","unstructured":"Yan H, Ji X, Li B. Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery. Front Immunol. 2025;16:1572034.","journal-title":"Front Immunol"},{"issue":"1","key":"2146_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-025-00650-x","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, Yu Z, Zhao Y, Jiang K, Hang Z, Huang X, Ma H, Wang L, Li Z, Wu M, Fan J, Luo W, Qin C, Zhou W, Nie J. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. Biol Direct. 2025;20(1):56.","journal-title":"Biol Direct"},{"key":"2146_CR28","doi-asserted-by":"publisher","first-page":"102349","DOI":"10.1016\/j.tranon.2025.102349","volume":"54","author":"X Zhang","year":"2025","unstructured":"Zhang X, Li P, Ji L, Zhang Y, Zhang Z, Guo Y, Zhang L, Jing S, Dong Z, Tian J, Yang L, Ding H, Yang E, Wang Z. A machine learning-based prognostic signature utilizing MSC proteomics for predicting bladder cancer prognosis and treatment response. Transl Oncol. 2025;54:102349.","journal-title":"Transl Oncol"},{"key":"2146_CR29","doi-asserted-by":"publisher","first-page":"1427661","DOI":"10.3389\/fimmu.2024.1427661","volume":"15","author":"YC Jiang","year":"2024","unstructured":"Jiang YC, Xu QT, Wang HB, Ren SY, Zhang Y. A novel prognostic signature related to programmed cell death in osteosarcoma. Front Immunol. 2024;15:1427661.","journal-title":"Front Immunol"},{"issue":"1","key":"2146_CR30","doi-asserted-by":"publisher","first-page":"e23495","DOI":"10.1016\/j.heliyon.2023.e23495","volume":"10","author":"D Feng","year":"2024","unstructured":"Feng D, Tuo Z, Wang J, Ye L, Li D, Wu R, Wei W, Yang Y, Zhang C. Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients. Heliyon. 2024;10(1):e23495.","journal-title":"Heliyon"},{"issue":"1","key":"2146_CR31","doi-asserted-by":"publisher","first-page":"22976","DOI":"10.1038\/s41598-024-73571-w","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang Q. Leveraging programmed cell death signature to predict clinical outcome and immunotherapy benefits in postoperative bladder cancer. Sci Rep. 2024;14(1):22976.","journal-title":"Sci Rep"},{"key":"2146_CR32","doi-asserted-by":"crossref","unstructured":"Li C, Qin W, Hu J, Lin J, Mao Y. A Machine Learning Computational Framework Develops a Multiple Programmed Cell Death Index for Improving Clinical Outcomes in Bladder Cancer, Biochem Genet (2024).","DOI":"10.1007\/s10528-024-10683-y"},{"issue":"8","key":"2146_CR33","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41417-024-00806-3","volume":"31","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zheng T, Qin C, Zhang X, Lin H, Huang X, Liu Q, Chang S, Zhang L, Guo J, Zhang Y, Bian C, Liu H. CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status. Cancer Gene Ther. 2024;31(8):1151\u201363.","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"2146_CR34","doi-asserted-by":"publisher","first-page":"e0279851","DOI":"10.1371\/journal.pone.0279851","volume":"17","author":"W Zeng","year":"2022","unstructured":"Zeng W, Wu M, Cheng Y, Liu L, Han Y, Xie Q, Li J, Wei L, Fang Y, Chen Y, Peng J, Shen A. CCT6A knockdown suppresses osteosarcoma cell growth and Akt pathway activation in vitro. PLoS ONE. 2022;17(12):e0279851.","journal-title":"PLoS ONE"},{"issue":"7664","key":"2146_CR35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23270","volume":"547","author":"RT Manguso","year":"2017","unstructured":"Manguso RT, Pope HW, Zimmer MD, Brown FD, Yates KB, Miller BC, Collins NB, Bi K, LaFleur MW, Juneja VR, Weiss SA, Lo J, Fisher DE, Miao D, Van Allen E, Root DE, Sharpe AH, Doench JG, Haining WN. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 2017;547(7664):413\u20138.","journal-title":"Nature"},{"issue":"10","key":"2146_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41590-019-0480-4","volume":"20","author":"MW LaFleur","year":"2019","unstructured":"LaFleur MW, Nguyen TH, Coxe MA, Miller BC, Yates KB, Gillis JE, Sen DR, Gaudiano EF, Al Abosy R, Freeman GJ, Haining WN, Sharpe AH. PTPN2 regulates the generation of exhausted CD8(+) T cell subpopulations and restrains tumor immunity. Nat Immunol. 2019;20(10):1335\u201347.","journal-title":"Nat Immunol"},{"issue":"1","key":"2146_CR37","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1038\/s41467-023-40170-8","volume":"14","author":"S Liang","year":"2023","unstructured":"Liang S, Tran E, Du X, Dong J, Sudholz H, Chen H, Qu Z, Huntington ND, Babon JJ, Kershaw NJ, Zhang ZY, Baell JB, Wiede F, Tiganis T. A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity. Nat Commun. 2023;14(1):4524.","journal-title":"Nat Commun"},{"key":"2146_CR38","doi-asserted-by":"publisher","first-page":"805311","DOI":"10.3389\/fimmu.2022.805311","volume":"13","author":"W Kuang","year":"2022","unstructured":"Kuang W, Wang X, Ding J, Li J, Ji M, Chen W, Wang L, Yang P. PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis. Front Immunol. 2022;13:805311.","journal-title":"Front Immunol"},{"issue":"52","key":"2146_CR39","doi-asserted-by":"publisher","first-page":"18343","DOI":"10.1074\/jbc.RA119.011060","volume":"295","author":"Z Huang","year":"2020","unstructured":"Huang Z, Liu M, Li D, Tan Y, Zhang R, Xia Z, Wang P, Jiao B, Liu P, Ren R. PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells. J Biol Chem. 2020;295(52):18343\u201354.","journal-title":"J Biol Chem"},{"issue":"3","key":"2146_CR40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.immuni.2025.02.007","volume":"58","author":"C Luo","year":"2025","unstructured":"Luo C, Zhang R, Guo R, Wu L, Xue T, He Y, Jin Y, Zhao Y, Zhang Z, Zhang P, Ye S, Li X, Li D, Zhang W, Wang C, Lai L, Pan-Hammarstrom Q, Wucherpfennig KW, Gao Z, Pan D, Zeng Z. Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells. Immunity. 2025;58(3):745\u2013e7659.","journal-title":"Immunity"},{"issue":"7769","key":"2146_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572(7769):402\u20136.","journal-title":"Nature"},{"issue":"10","key":"2146_CR42","doi-asserted-by":"publisher","first-page":"e2207693","DOI":"10.1002\/advs.202207693","volume":"10","author":"H Kim","year":"2023","unstructured":"Kim H, Villareal LB, Liu Z, Haneef M, Falcon DM, Martin DR, Lee HJ, Dame MK, Attili D, Chen Y, Varani J, Spence JR, Kovbasnjuk O, Colacino JA, Lyssiotis CA, Lin HC, Shah YM. Xue, Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis. Adv Sci (Weinh). 2023;10(10):e2207693.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2146_CR43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40537-022-00641-z","volume":"9","author":"CP Gui","year":"2022","unstructured":"Gui CP, Li JY, Fu LM, Luo CG, Zhang C, Tang YM, Zhang LZ, Shu GN, Wu RP, Luo JH. Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer. J Big Data. 2022;9(1):88.","journal-title":"J Big Data"},{"issue":"1","key":"2146_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41420-021-00749-w","volume":"7","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Zhang X, Dong W. TRAF7 contributes to tumor progression by promoting ubiquitin-proteasome mediated degradation of P53 in hepatocellular carcinoma. Cell Death Discov. 2021;7(1):352.","journal-title":"Cell Death Discov"},{"issue":"3","key":"2146_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41436-019-0669-9","volume":"22","author":"E Sanchez","year":"2020","unstructured":"Sanchez E, Laplace-Builhe B, Mau-Them FT, Richard E, Goldenberg A, Toler TL, Guignard T, Gatinois V, Vincent M, Blanchet C, Boland A, Bihoreau MT, Deleuze JF, Olaso R, Nephi W, Ludecke HJ, Verheij J, Moreau-Lenoir F, Denoyelle F, Riviere JB, Laplanche JL, Willing M, Captier G, Apparailly F, Wieczorek D, Collet C, Djouad F, Genevieve D. POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4. Genet Med. 2020;22(3):547\u201356.","journal-title":"Genet Med"},{"issue":"1","key":"2146_CR46","first-page":"671","volume":"19","author":"F Yang","year":"2020","unstructured":"Yang F, Liu H, Zhao J, Ma X, Qi W. POLR1B is upregulated and promotes cell proliferation in non-small cell lung cancer. Oncol Lett. 2020;19(1):671\u201380.","journal-title":"Oncol Lett"},{"issue":"10","key":"2146_CR47","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.18632\/aging.101573","volume":"10","author":"H Liu","year":"2018","unstructured":"Liu H, Chen D, Bi J, Han J, Yang M, Dong W, Lin T, Huang J. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer. Aging. 2018;10(10):2606\u201323.","journal-title":"Aging"},{"issue":"5","key":"2146_CR48","doi-asserted-by":"publisher","first-page":"e12060","DOI":"10.1002\/jev2.12060","volume":"10","author":"X Gao","year":"2021","unstructured":"Gao X, Wang Y, Lu F, Chen X, Yang D, Cao Y, Zhang W, Chen J, Zheng L, Wang G, Fu M, Ma L, Song Y, Zhan Q. Extracellular vesicles derived from oesophageal cancer containing P4HB promote muscle wasting via regulating PHGDH\/Bcl-2\/caspase-3 pathway. J Extracell Vesicles. 2021;10(5):e12060.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2146_CR49","first-page":"231","volume":"19","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Yang J, Zhang Q, Xu Q, Lu L, Wang J, Xia W. P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling. Mol Med Rep. 2019;19(1):231\u20137.","journal-title":"Mol Med Rep"},{"issue":"5","key":"2146_CR50","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/neuonc\/not005","volume":"15","author":"S Sun","year":"2013","unstructured":"Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee NP, Day PJ, Lui WM, Fung CF, Leung GK. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Neuro Oncol. 2013;15(5):562\u201377.","journal-title":"Neuro Oncol"},{"key":"2146_CR51","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.2147\/OTT.S267734","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang X, Bai Y, Zhang F, Yang Y, Feng D, Li A, Yang Z, Li D, Tang Y, Wei X, Wei W, Han P. Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder. Onco Targets Ther. 2020;13:9543\u201358.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2146_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3892\/ol.2020.11569","volume":"20","author":"X Ma","year":"2020","unstructured":"Ma X, Wang J, Zhuang J, Ma X, Zheng N, Song Y, Xia W. P4HB modulates epithelial-mesenchymal transition and the beta-catenin\/Snail pathway influencing chemoresistance in liver cancer cells. Oncol Lett. 2020;20(1):257\u201365.","journal-title":"Oncol Lett"},{"issue":"2","key":"2146_CR53","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/cas.16052","volume":"115","author":"R Huang","year":"2024","unstructured":"Huang R, Wu D, Zhang K, Hu G, Liu Y, Jiang Y, Wang C, Zheng Y. ARID1A loss induces P4HB to activate fibroblasts to support lung cancer cell growth, invasion, and chemoresistance. Cancer Sci. 2024;115(2):439\u201351.","journal-title":"Cancer Sci"},{"issue":"45","key":"2146_CR54","doi-asserted-by":"publisher","first-page":"19085","DOI":"10.1021\/jacs.0c06709","volume":"142","author":"YC Chen","year":"2020","unstructured":"Chen YC, Oses-Prieto JA, Pope LE, Burlingame AL, Dixon SJ, Renslo AR. Reactivity-Based Probe of the Iron(II)-Dependent Interactome Identifies New Cellular Modulators of Ferroptosis. J Am Chem Soc. 2020;142(45):19085\u201393.","journal-title":"J Am Chem Soc"},{"key":"2146_CR55","doi-asserted-by":"publisher","first-page":"12443","DOI":"10.2147\/OTT.S281713","volume":"13","author":"W Li","year":"2020","unstructured":"Li W, Zhang Y, Li Y, Cao Y, Zhou J, Sun Z, Wu W, Tan X, Shao Y, Xie K. Yan, Profiling Analysis Reveals the Crucial Role of the Endogenous Peptides in Bladder Cancer Progression. Onco Targets Ther. 2020;13:12443\u201355.","journal-title":"Onco Targets Ther"},{"key":"2146_CR56","doi-asserted-by":"publisher","first-page":"1253586","DOI":"10.3389\/fimmu.2023.1253586","volume":"14","author":"S Xiong","year":"2023","unstructured":"Xiong S, Li S, Zeng J, Nie J, Liu T, Liu X, Chen L, Fu B, Deng J, Xu S. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB. Front Immunol. 2023;14:1253586.","journal-title":"Front Immunol"},{"issue":"1","key":"2146_CR57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12894-023-01331-5","volume":"23","author":"Z Zou","year":"2023","unstructured":"Zou Z, Li Z, Sun W, Gao W, Liu B, Liu J, Guo Y. Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression. BMC Urol. 2023;23(1):167.","journal-title":"BMC Urol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02146-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T08:02:15Z","timestamp":1775203335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02146-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02146-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of the First Affiliated Hospital of Soochow University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"214"}}